Postdoctoral fellow in Human Microbiome research at the University of Calgary, Canada
A postdoctoral research position is available in the Western Canadian Microbiome Centre (WCMC) of the Cumming School of Medicine at the University of Calgary, in Canada. This fully funded position is available to an enthusiastic candidate interested in studying the role of the gut microbiome in chronic inflammatory diseases.
Candidates with strong background and hands-on experience in microbiology, cell and molecular biology, and / or immunology are encouraged to apply. The candidate should have recently completed or about to complete his/her Ph.D in microbiology, immunology, medicine or related field. Expertise or prior work with animal models and intestinal bacteria, and bioinformatics analysis of the microbiome will be extremely valuable. Excellent writing and oral presentation skills, the ability to work independently and with collaborators, and the ability to multitask and meet deadlines is required.
This position is available immediately (flexible start date) to work in the laboratory of Assistant Professor Marie-Claire Arrieta, within the WCMC. Her research program is aimed at studying the assembly of the gut microbiome early in life and how alterations in the early life microbiome play a role in the pathogenesis of asthma and IBD. Utilizing results from human cohort studies, as well as mechanistic work in in vivo models, our research program uses a systems biology approach to integrate multi-omic data, coupled with confirmatory molecular biology-based analysis on the bench. This approach allows to address the general research question of how metabolites originated from alterations in early-life intestinal microbiota contribute to IBD and asthma.
The ideal candidate will have a record of scientific rigor, creativity, and ability to work in teams, with a strong publication record in peer-reviewed scientific journals.
The WCMC supports end-to-end integration of microbiome research in Western Canada from discovery to therapeutic, diagnostic and technological applications. Its platforms include: a state-of-the-art gnotobiotic animal facility, imaging platform with real-time in vitro and in vivo capacity, genomics, proteomics, metabolomics and bioinformatics platforms.